CARBOPLATIN AND GEMCITABINE IN ELDERLY AND/OR FRAIL PATIENTS (PTS) WITH ADVANCED TRANSITIONAL CELL CARCINOMA (TCC): A PHASE II STUDY

被引：0
|
作者：
Baitar, A. [1 ]
De Vos, M. [1 ]
Vandebroek, A. [1 ]
Schrijvers, D. [1 ]
机构：
[1] ZNA Middelheim, Dept Med Oncol, Antwerp, Belgium
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [1] Gemcitabine (G) and vinorelbine (V) in pretreated or elderly transitional cell carcinoma (TCC) patients (PTS): A phase II study
    Ferrau, F
    Bordonaro, R
    Aiello, R
    Cordio, S
    Failla, M
    Giuffrida, D
    Lavenia, G
    Pappalardo, A
    Priolo, D
    Failla, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S352 - S352
  • [2] A phase II trial of gemcitabine and carboplatin (GC) in patients with transitional cell carcinoma of the urinary tract (TCC).
    Olivares, J
    Hyman, W
    Senzer, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 404S - 404S
  • [3] Phase II study of Taxol (paclitaxel) and Carboplatin in patients with advanced transitional-cell carcinoma of the urothelium (TCC)
    Mottet, N
    Prapotnich, D
    Beuzeboc, P
    Di Palma, M
    Bui, N
    Eymard, JC
    Mercat, A
    Garet, F
    Droz, JP
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 59 - 59
  • [4] A phase II trial of gemcitabine (G), carboplatin (C), and sorafenib (S) in patients (pts) with transitional cell carcinoma (TCC): Preliminary safety and outcome
    Mehnert, J. M.
    Mortazavi, A.
    Stein, M. N.
    Donadio, A. C.
    Zelterman, D.
    McDonough, J. A.
    Rowen, E.
    Hoimes, C. J.
    Gibney, G.
    Kelly, W. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [5] Gemcitabine in the treatment of patients with advanced transitional cell carcinoma: A phase II study
    Kuzel, T
    Stadler, W
    Raghavan, D
    Levine, E
    Vogelzang, N
    Roth, B
    Dorr, FA
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1152 - 1152
  • [6] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Nong Xu
    Xiao Chen Zhang
    Jian Ping Xiong
    Wei Jia Fang
    Lan Fang Yu
    Jiong Qian
    Ling Zhang
    [J]. BMC Cancer, 7
  • [7] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Xu, Nong
    Zhang, Xiao Chen
    Xiong, Jian Ping
    Fang, Wei Jia
    Yu, Lan Fang
    Qian, Jiong
    Zhang, Ling
    [J]. BMC CANCER, 2007, 7 (1)
  • [8] A phase II monocentric study of oxaliplatin (Ox) in combination with gemcitabine (Gem) (GEMOX) in patients (pts) with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.
    Theodore, C
    Bidault, F
    Fizazi, K
    Di Palma, M
    Wibault, P
    Bouvet-Forteau, N
    Laplanche, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 401S - 401S
  • [9] Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): A phase II multicenter trial
    Mancarella, S
    Lorusso, V
    Manzione, L
    Antimi, M
    De Vita, F
    Santoro, A
    Maiorino, L
    Mattioli, R
    Luporini, G
    Bilancia, D
    De Lena, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S347 - S348
  • [10] A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract
    Theodore, C.
    Bidault, F.
    Bouvet-Forteau, N.
    Abdelatif, M.
    Fizazi, K.
    di Palma, M.
    Wibault, P.
    de Crevoisier, R.
    Laplanche, A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (06) : 990 - 994
12345